Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewscoronavirus

Big Story | Serum Institute to seek Rs 100 crore In damages from vaccine volunteer: A look at Covishield legal row

The 40-year-old volunteer claimed that he contracted severe neurological disorders after being vaccinated with Covidshield shots under development at Serum Institute of India. All you need to know about the legal hassle.

November 30, 2020 / 05:38 PM IST
As questions mounted on Oxford-AstraZeneca vaccine trials in India after a 40-year-old participant fell sick and sought damages of Rs 5 crore, Serum Institute of India responded to allegations by preparing a Rs 100 crore defamation suit against him.
Moneycontrol News
first published: Nov 30, 2020 05:37 pm
Sections